All Stories

  1. A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Safety, Pharmacokinetics, and Biomarker Results of Subcutaneous Bapineuzumab in Patients with mild to moderate Alzheimer’s disease

    Article • Journal of Alzheimer s Disease, October 2016, IOS Press

    Dr Gerald P Novak

  2. Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer’s Disease

    Article • Journal of Alzheimer s Disease, November 2015, IOS Press

    Dr Gerald P Novak

  3. Age-Stratified Prevalence of Mild Cognitive Impairment and Dementia in European Populations: A Systematic Review

    Article • Journal of Alzheimer s Disease, September 2015, IOS Press

    Dr Gerald P Novak

  4. Current Developments in Dementia Risk Prediction Modelling: An Updated Systematic Review

    Article • PLoS ONE, September 2015, PLOS

    Dr Gerald P Novak

  5. Multivariate prediction of change in hippocampal volume in Alzheimer’s disease

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  6. Clinical characteristics of subjects with conflicting biomarkers of amyloid deposition

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  7. The impact of reference region on the variance of estimated change in PET amyloid standard uptake value ratios measured longitudinally in summit and acction

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  8. Creating normative values for cognitive tests in amyloid positive and amyloid negative cognitively normal subjects

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  9. Operationalizing the iwg2 and nia-aa diagnostic criteria for asymptomatic-at-risk for Alzheimer's disease or preclinical Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  10. Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC-001) in mild-to-moderate and early Alzheimer’s disease

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  11. Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB)

    Article • Alzheimer s & Dementia, July 2015, Elsevier

    Dr Gerald P Novak

  12. POPULATION CHARACTERIZATION IN THE EARLY STAGES OF ALZHEIMER'S DISEASE

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  13. EFFICACY AND SAFETY OF MONTHLY SUBCUTANEOUS BAPINEUZUMAB

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  14. RATES OF CHANGE IN BRAIN VOLUME WITH SUBCUTANEOUS BAPINEUZUMAB

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  15. EVALUATION OF CEREBRAL GRAY MATTER AND PONS AS REFERENCE REGIONS FOR AMYLOID PET: RESULTS FROM A BAPINEUZUMAB SUBCUTANEOUS PHASE 2 TRIAL

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  16. COMPARISON OF THREE NORMATIVE DATA CORRECTION APPROACHES: A CROSS-SECTIONAL EVALUATION IN THE AIBL STUDY

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  17. VALIDATION OF NOVEL COMPOSITE OUTCOME MEASURES FOR PRE-DEMENTIA ALZHEIMER'S DISEASE

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  18. A PROSPECTIVE, SYSTEMATIC LITERATURE REVIEW AND META-ANALYSES TO EVALUATE GLOBAL AND REGIONAL BRAIN VOLUMES BY STRUCTURAL MRI AS BIOMARKERS OF ALZHEIMER'S DISEASE (AD) PROGRESSION

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  19. RISK PREDICTION MODELS FOR DEMENTIA: A SYSTEMATIC REVIEW

    Article • Alzheimer s & Dementia, July 2014, Elsevier

    Dr Gerald P Novak

  20. Disease progression model for Clinical Dementia Rating–Sum of Boxes in mild cognitive impairment and Alzheimer’s subjects from the Alzheimer’s Disease Neuroimaging Initiative

    Article • May 2014, Taylor & Francis

    Dr Gerald P Novak, Mahesh Samtani

  21. On the selection of cognitive and functional markers of brain volume and atrophy

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Dr Gerald P Novak

  22. The impact of gradient field distortion on the calculation of brain atrophy in Alzheimer's disease, derived from volumetric MRI using the boundary shift integral

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Dr Gerald P Novak

  23. Correlation of brain atrophy with clinical progression in mild-to-moderate Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Dr Gerald P Novak

  24. Biomarker strategy for enrichment and monitoring of biological effect in ACCTION, a phase II study of ACC-001 (vanutide cridificar) for Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Dr Gerald P Novak

  25. The rate of clinical progression and brain atrophy is greater with increasing severity of Alzheimer's disease: Results from the volumetric MRI substudies of two phase III trials with bapineuzumab

    Article • Alzheimer s & Dementia, July 2013, Elsevier

    Dr Gerald P Novak

  26. The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials

    Article • Alzheimer s & Dementia, February 2013, Elsevier

    Dr Gerald P Novak

  27. Structural Magnetic Resonance Imaging as a Biomarker for the Diagnosis, Progression, and Treatment of Alzheimer Disease

    Article • January 2013, Elsevier

    Dr Gerald P Novak

  28. Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes

    Article • British Journal of Clinical Pharmacology, December 2012, Wiley

    Dr Gerald P Novak

  29. Impact of hippocampal volume-based enrichment on clinical outcomes in prodromal Alzheimer's disease trials up to 3 years' follow-up

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Dr Gerald P Novak

  30. A new level of operational complexity within innovative Alzheimer's disease trial designs: Case study of a phase 2 bapineuzumab trial—SUMMIT-AD

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Dr Gerald P Novak

  31. Discordance for hippocampal atrophy and amyloid burden in amnestic mild cognitive impairment may identify distinct subgroups of patients

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Dr Gerald P Novak

  32. Choice of threshold hippocampal volume as a selection criterion in prodromal Alzheimer's disease

    Article • Alzheimer s & Dementia, July 2012, Elsevier

    Dr Gerald P Novak

  33. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data

    Article • BMC Neurology, January 2012, Springer Science + Business Media

    Dr Gerald P Novak

  34. Cognitive effects of carisbamate in randomized, placebo-controlled, healthy-volunteer, multidose studies

    Article • Epilepsy & Behavior, October 2011, Elsevier

    Dr Gerald P Novak

  35. A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures

    Article • Epilepsia, February 2011, Wiley

    Dr Gerald P Novak

  36. Abstract #8: Trial Methodology of a Randomized, Double-blind, Parallel-Group Study Evaluating the Clinical Effectiveness of Carisbamate, Topiramate, and Levetiracetam As Adjunctive Treatment of Partial Onset Seizures in Adults

    Article • Neurotherapeutics, July 2010, Springer Science + Business Media

    Dr Gerald P Novak

  37. Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials

    Article • Epilepsia, March 2010, Wiley

    Dr Gerald P Novak

  38. Pharmacokinetics of carisbamate (RWJ-333369) in healthy Japanese and Western subjects

    Article • Epilepsia, August 2009, Wiley

    Dr Gerald P Novak

  39. Evaluation of Carisbamate for the Treatment of Migraine in a Randomized, Double-Blind Trial

    Article • Headache The Journal of Head and Face Pain, February 2009, Wiley

    Dr Gerald P Novak

  40. Brainstem Glioma Presenting as Paroxysmal Headache

    Article • Developmental Medicine & Child Neurology, November 2008, Wiley

    Dr Gerald P Novak

  41. Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly

    Article • Epilepsy Research, March 2008, Elsevier

    Dr Gerald P Novak

  42. An Interaction Study Between the New Antiepileptic and CNS Drug Carisbamate (RWJ-333369) and Lamotrigine and Valproic Acid

    Article • Epilepsia, July 2007, Wiley

    Dr Gerald P Novak

  43. Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: An exploratory, placebo-controlled study

    Article • Epilepsy Research, May 2007, Elsevier

    Dr Gerald P Novak

  44. Carisbamate (RWJ-333369)

    Article • Neurotherapeutics, January 2007, Springer Science + Business Media

    Dr Gerald P Novak

  45. Pharmacokinetics of the New Antiepileptic and CNS Drug RWJ-333369 Following Single and Multiple Dosing to Humans

    Article • Epilepsia, November 2006, Wiley

    Dr Gerald P Novak

  46. Pharmacokinetic Interaction Study between the New Antiepileptic and CNS Drug RWJ-333369 and Carbamazepine in Healthy Adults

    Article • Epilepsia, November 2006, Wiley

    Dr Gerald P Novak

  47. P4-007 Galantamine in the treatment of patients with mild cognitive impairment: effect of diagnostic type at baseline

    Article • Neurobiology of Aging, July 2004, Elsevier

    Dr Gerald P Novak

  48. The role of functional MR in the evaluation and management of epilepsy patients

    Article • NeuroImage, June 2001, Elsevier

    Dr Gerald P Novak

  49. The Role of Brain Computed Tomography in Evaluating Children with New Onset of Seizures in the Emergency Department

    Article • Epilepsia, August 2000, Wiley

    Dr Gerald P Novak

  50. Effects of risperidone on auditory event-related potentials in schizophrenia

    Article • The International Journal of Neuropsychopharmacology, December 1999, Oxford University Press (OUP)

    Dr Gerald P Novak

  51. Effects of clozapine on auditory event-related potentials in schizophrenia

    Article • Biological Psychiatry, October 1998, Elsevier

    Dr Gerald P Novak

  52. Symptoms of Depression and Anxiety in Pediatric Epilepsy Patients

    Article • Epilepsia, June 1998, Wiley

    Dr Gerald P Novak

  53. Vector analysis of the lateralized readiness potential

    Article • Electroencephalography and Clinical Neurophysiology, January 1997, Elsevier

    Dr Gerald P Novak

  54. Spatial orienting and focused attention in attention deficit hyperactivity disorder

    Article • Psychophysiology, November 1995, Wiley

    Dr Gerald P Novak

  55. MRI in neonatal dural sinus thrombosis

    Article • Pediatric Neurology, May 1993, Elsevier

    Dr Gerald P Novak

  56. Mismatch Detection and the Latency of Temporal Judgments

    Article • Psychophysiology, July 1992, Wiley

    Dr Gerald P Novak

  57. The Chronometry of Attention-Modulated Processing and Automatic Mismatch Detection

    Article • Psychophysiology, July 1992, Wiley

    Dr Gerald P Novak

  58. Differentiation of negative event-related potentials in an auditory discrimination task

    Article • Electroencephalography and Clinical Neurophysiology, April 1990, Elsevier

    Dr Gerald P Novak

  59. Cortical responses to speech sounds and their formants in normal infants: maturational sequence and spatiotemporal analysis

    Article • Electroencephalography and Clinical Neurophysiology, October 1989, Elsevier

    Dr Gerald P Novak

  60. Utility of visual evoked potentials using hemifield stimulation and several check sizes in the evaluation of suspected multiple sclerosis

    Article • Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section, January 1988, Elsevier

    Dr Gerald P Novak

  61. Ethanolamine Kinase Activity in Purified Myelin of Rat Brain

    Article • Journal of Neurochemistry, January 1987, Wiley

    Dr Gerald P Novak

  62. Valproic acid in the treatment of Sydenham chorea

    Article • Pediatric Neurology, September 1985, Elsevier

    Dr Gerald P Novak

  63. Carisbamate

    Article • Wiley

    Dr Gerald P Novak